Need a ROBO2 antibody? Anti-ROBO2 [IPI-ROBO2.47] just joined our Axon Guidance Antibody Collection. This (human) chimeric recombinant antibody has fused human variable and rabbit constant domains, and is recommended for flow cytometry and immunocytochemistry. Find out more: buff.ly/7OG3Ihl
Institute for Protein Innovation
@ipiproteins.bsky.social
We advance protein science to accelerate research & improve human health | proteininnovation.org
Working with Neuroligins? IPI offers recombinant antibodies targeting NLGN1, NLGN2 and NLGN3. Our latest addition, IPI-NLGN1.15, is selective (non-cross-reactive with other NLGNs) and recommended for use in flow, IF and IHC. View the validation data and learn more: buff.ly/mOTAfGY #Neuroligin
That's a wrap on IPI's recent Introduction to Automated Liquid Handling course! Thanks to our participants, and to @sptlabtech.bsky.social and @novabiomedical.bsky.social for their support. More protein science courses are coming—join our mailing list for education updates: buff.ly/nzyAQUW
IPI often hears about a mismatch between traditional lab coursework and real bioscience needs. To fill that gap, we joined Emmanuel College students this week to offer technical skills in lab automation plus insights into when/how to apply those skills. Here's what that looks like ⬇️
Not all adhesion molecules are created equal 🤔. NLGN1 is a key synaptic organizer, and you need an antibody that won't cross-react with other neuroligins and muddy your results. @ipiproteins.bsky.social's new recombinant anti-NLGN1 antibody (IPI-NLGN1.15) is now available: https://twp.ai/4ht1Pn
What can we extract from our #antibody selection data? Certainly more — with #AI on our side. Read how IPI and collaborators @harvardmed.bsky.social applied #machinelearning and #artificialintelligence to streamline #antibodydiscovery for cell surface #antigens. buff.ly/mjJhtUs
Machining antibodies at IPI
Very little these days escapes the reach of machine learning (ML) and, more broadly, artificial intelligence (AI). Antibodies have caught the AI train, as over
buff.ly
#EUSYN26 Speaker alert! Monika Brill (@tum.de) and Rob Meijers (@ipiproteins.bsky.social) at the 10th European Synapse Meeting! 📅 21-23 Oct 🪧 University Halls @kuleuvenuniversity.bsky.social More: www.vibconferences.be/events/europ...
Two new antibodies just hit our collections! ➕ Anti-ROBO2 [IPI-ROBO2.47] ➕ Anti-Neuroligin-1 [IPI-NLGN1.15] Explore our recombinant antibodies for ROBOs, Neuroligins and other axon guidance and synaptic cleft targets: buff.ly/nIfPvy6 #Robo #Neuroligin
Last chance to register for IPI's Introduction to Automated Liquid Handling course. Hands-on OT-2 training, Python-based method development, automation workflow design, and expert-led discussions. 📅 July 23-24 📍 Boston Register now: buff.ly/e89E45Y
Did you know that IPI has stores of antibodies ready for your lab’s next experiment? We understand the setbacks of bad antibodies and strive for you to be able to trust your results. Explore our collections and order today 🧪 buff.ly/6R9zi4n
Scale-up and automate your workflows with IPI’s two-day interactive course, July 23-24, featuring: Lectures on the core principles of automated liquid handling Q&As w/ IPI lab experts & an automated systems tour Liquid handler experience & method development w/ Python Register now: buff.ly/YWG7qhs
IPI has monoclonal antibodies designed for researchers exploring axon guidance and the synaptic cleft. Take a look at our latest additions targeting #Semaphorins, #Neuropilins and #Neurexins ➡️ buff.ly/nQhvIjU
Protein tools
IPI is proud to provide high-quality, well-validated recombinant antibodies and other protein tools to the biological research community. We prioritize difficul
buff.ly
🧪 Recombinant anti-NRP1 antibodies from @ipiproteins.bsky.social are now available at Addgene. Researchers can use IPI-mNRP1.17 and IPI-mNRP1.23 for FC, IHC, and ICC in mouse and human — with no cross-reactivity to NRP2. 🎯 Check out the antibodies here:
Addgene: IPI Antibody Collection
Find unique recombinant antibodies targeting families of cell surface and secreted proteins from a collaboration between Addgene and IPI.
twp.ai
Can #machinelearning really accelerate antibody discovery? In a new Cell Systems @cellpress.bsky.social paper, our team shows ML’s potential to enhance #antibodydiscovery when fed well-curated #datasets of #antibody/#antigen interactions 👏 👏 👏 buff.ly/MKZY96Q
Machining antibodies at IPI
Very little these days escapes the reach of machine learning (ML) and, more broadly, artificial intelligence (AI). Antibodies have caught the AI train, as over
proteininnovation.org
IPI is headed to Barcelona for #FENS2026 this week! 🧑🔬 Find Travis Riedel at Poster PS07-10AM-052 (July 10) to explore our antibody panels for synaptic cleft receptors 🧑🔬 Hear from @addgene.bsky.social about AAVs, antibodies, the Addgene Data Hub at Booth 147 & Poster PS04-08PM-680 (July 8)
FENS Forum 2026 | Barcelona, 6-10 July
Advancing Neuroscience Together
buff.ly
Researchers across academia and industry, in labs small and large, are using automation to improve reproducibility and scale workflows. Learn the fundamentals in IPI's hands-on course this July. Register: buff.ly/TVFyfbB
IPI founder @timothyspringer.bsky.social was named to @Forbes’ 250 great American innovators list earlier this year. Hear his talk on the antibody revolution, given at the America Innovates Expo this May, where IPI joined to showcase basic science 🔊
The Antibody Revolution: Research, Therapeutics and Me
buff.ly
New antibody alert 🧪Anti-NRXN3a just joined our Synaptic Cleft Antibody Collection. Order now: buff.ly/VwjVHuw #Neurexin
New to #labautomation? IPI's Intro to Automated Liquid Handling course is designed for researchers at all experience levels. Learn liquid handling fundamentals, build workflows on an Opentrons OT-2, and explore real-world automation systems used in #antibodydiscovery. Register ➡️ buff.ly/sTTJvBQ
A look back to IPI’s yeast display course earlier this month! What an amazing cohort, determined to expand their grasp of display technologies and bring these lessons back to labs around the world. Our next course, an intro to lab automation, is happening July 23-24 — sign up now! buff.ly/E2K6ytH
New axon guidance antibody alert 🧪 ➕ Anti-#SEMA6A/7A ➕ Anti-#NRP1 IPI recombinant monoclonals are designed to be mouse- and human-reactive, non-cross-reactive with other protein family members and IPI-validated for flow cytometry and immunofluorescence. View the datasheets: buff.ly/G35AqDh
Less than one month left to register for IPI’s Automated Liquid Handling course 🔔 This course is designed by IPI’s automation team to provide students, researchers, and lab personnel at all levels with support and hands-on skills for developing large-scale assays. Grab your spot: buff.ly/pnh3UtQ
Meet #AlloyScholar Shelby Harris! Shelby, a @vanderbilt.edu PhD student, joined our 2026 Yeast Display course to learn #Abengineering methods to study G6P's role in #glucoseproduction. Thanks Alloy Therapeutics for supporting this year’s Scholars! Get IPI updates: buff.ly/a7XyBij
Just out @cellpress.bsky.social! Led by Deepash Kothiwal & co-authored by 20+ IPI lab members, the paper reports a novel framework to streamline antibody development, generate ML-compatible datasets and identify functional binders missed by experimental selection. Read the paper: buff.ly/Qq5OnMu
Looking for a dependable #isotypecontrol antibody? Our #MOPC-21 recombinant rabbit IgG is compatible with all IPI rabbit IgG antibodies and, as a consistent non-binder, supports accurate assessment of family-wide cross-reactivity. Order now: buff.ly/gU0M1ZE
#AlloyScholar Lorenzo Agostini (NIH) joined IPI’s #YeastDisplay course this month to learn cutting-edge antibody discovery and engineering techniques alongside fellow translational researchers. Thanks, Alloy Therapeutics, for the support! Get IPI education updates: buff.ly/a7XyBij
IPI platform director André Teixeira walked through the architecture of IPI’s platform, built to combine #yeastsurfacedisplay, #labautomation and #AI-guided clone triage toward faster #antibodydiscovery. Listen to the full talk @milaboratories.bsky.social ➡️
End-to-End Antibody Discovery: Yeast Display, Automation, AI, and Multispecifics
Our High-Affinity Talks features Andre Texeira from the Institute for Protein Innovation. Most of the human surfaceome and secretome still lack monoclonals validated for anything beyond western…
buff.ly
Scale-up and automate your workflows! Join us for a two-day interactive course, happening July 23-24. Register now: buff.ly/GWBG1yq
Deb Moshinsky, IPI characterization and validation director, will speak on a panel at Reproducibility in Science: Elevating Standards to Strengthen Research next week! Join her at Hood College on June 17! More info: bit.ly/4au4hVM
Reproducibility in Science 2026 | Frederick National Laboratory
Join us for the 2026 edition of the Hood College – Frederick National Laboratory Life Sciences Symposium, which showcases topics in life sciences with an interdisciplinary focus.
bit.ly
Last week’s course was a big success, thanks to our guest speakers! Dane Wittrup @mitkochinstitute.bsky.social, Surge Biswas at Nabla Bio & Justin Peruzzi @aiproteins.com shared insights on yeast display, AI Ab design & miniprotein discovery. Sign up for future course updates ➡️ buff.ly/tTcDWZk